These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Viskaldix in the treatment of essential hypertension. A study on hospital out-patients. Cameron EG; Crowder D Practitioner; 1981 Apr; 225(1354):581-5. PubMed ID: 7279846 [No Abstract] [Full Text] [Related]
44. ["Viskaldix" in the treatment of arterial hypertension]. Bar-Andziak E; Brym E; Czerniewska E Kardiol Pol; 1984; 27(2):125-30. PubMed ID: 6374243 [No Abstract] [Full Text] [Related]
45. [Combination therapy of essential hypertension with beta receptor blockaders and diuretics]. Rosenthal J; Meurer KA; Escobar-Jimenez F; Laaser U; Lang R; Raptis S Verh Dtsch Ges Kreislaufforsch; 1977; 43():223-4. PubMed ID: 349926 [No Abstract] [Full Text] [Related]
46. [Experience with Viskaldix]. Jezersek P Lijec Vjesn; 1984; 106(11-12):518-20. PubMed ID: 6394940 [No Abstract] [Full Text] [Related]
47. The effect of once daily beta-adrenoceptor blocker-thiazide diuretic combination on the ambulatory blood pressure. Gould BA; Hornung RS; Kieso H; Mann S; Raftery EB Br J Clin Pharmacol; 1982 Dec; 14(6):827-31. PubMed ID: 6129883 [TBL] [Abstract][Full Text] [Related]
48. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension]. Török E; Jávor T; Szám I; Gábor G Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586 [No Abstract] [Full Text] [Related]
49. [Antihypertensive effectiveness of a guanfacine/clopamide combination]. Wetzels E; Weidinger G MMW Munch Med Wochenschr; 1982 Oct; 124(40):871-4. PubMed ID: 6815503 [No Abstract] [Full Text] [Related]
50. [Evaluation of the hypotensive effect of Viskaldix]. Wyrzykowski B; Suchecka-Rachoń K; Krupa-Wojciechowska B Przegl Lek; 1985; 42(11):750-4. PubMed ID: 3912842 [No Abstract] [Full Text] [Related]
51. [Evaluation of the therapeutic efficacy of a fixed combination of beta blockader and diuretic, in the treatment of systemic arterial hypertension. A multicenter study]. Zilenovski AM; Freire CA; Iverson MT Arq Bras Cardiol; 1984 Jun; 42(6):435-41. PubMed ID: 6393921 [No Abstract] [Full Text] [Related]
52. [Treatment of mild and moderate hypertension with viskaldix (author's transl)]. Voges D; Fryda-Kaurimsky Z Schweiz Rundsch Med Prax; 1978 Oct; 67(42):1554-7. PubMed ID: 704550 [No Abstract] [Full Text] [Related]
53. An office-based primary care trial of pindolol ('Visken') in essential hypertension. Marks AD; Finestone A; Sobel E; Lanzilotti S Curr Med Res Opin; 1986; 10(5):296-307. PubMed ID: 3545686 [TBL] [Abstract][Full Text] [Related]
54. [Long term study (1 year) with a beta receptor blocker-diuretic combination in hypertension treatment]. Gotzen R; Faupel RP; Hammerschmidt D Med Welt; 1981 Sep; 32(39):1450-2. PubMed ID: 7029197 [No Abstract] [Full Text] [Related]
55. A beta blocker-thiazide combination in the treatment of hypertension in diabetics. Chazan BI; Old JM; Venkataraman G; Snape J; Cameron EG Br J Clin Pract; 1981; 35(11-12):393-8. PubMed ID: 7030375 [No Abstract] [Full Text] [Related]
56. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial. Waal-Manning HJ; Simpson FO N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769 [No Abstract] [Full Text] [Related]
57. [Quantitative data on the additive effect of a beta-receptor blockader and a saluretic in the therapy of hypertension. Interindividual-component comparison in a doble-blind study]. Werning C; Hammerschmidt D; Kaiser Hj Med Welt; 1978 Oct; 29(40):1570-5. PubMed ID: 703579 [No Abstract] [Full Text] [Related]
58. [Treatment of essential hypertension with Viskaldix]. Gerc V; Numić N Lijec Vjesn; 1984; 106(11-12):515-7. PubMed ID: 6521607 [No Abstract] [Full Text] [Related]